Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma

Journal of Glaucoma

Volumn 18, Issue 4, 2009, Pages 288-292

  Holló, Gábor ^a   Kóthy, Péter ^a   Géczy, Anna ^b   Vargha, Péter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b PÁZMÁNY PÉTER CATHOLIC UNIVERSITY   (Hungary)

Author keywords

Adherence; Compliance; Depression; Glaucoma; Personality traits; Travalert dosing aid

Indexed keywords

TRAVOPROST;

ANXIETY; ARTICLE; BECK HOPELESSNESS SCALE; CONTROLLED STUDY; DEPRESSION; DEPRESSION INVENTORY; DEVICE; DISEASE SEVERITY; DRUG INSTILLATION; DRUG SELF ADMINISTRATION; EVENING DOSAGE; EYSENCK PERSONALITY QUESTIONNAIRE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT SATISFACTION; PERSONALITY; PRIORITY JOURNAL; SOCIAL STATUS; SOCIOECONOMICS; STATE TRAIT ANXIETY INVENTORY; TRAVERT DOSING AID; TREATMENT DURATION;

AGED; ANTIHYPERTENSIVE AGENTS; ANXIETY DISORDERS; CLOPROSTENOL; DEPRESSIVE DISORDER; DRUG MONITORING; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MEDICATION ADHERENCE; OCULAR HYPERTENSION; PATIENT EDUCATION AS TOPIC; PERSONALITY DISORDERS; QUESTIONNAIRES;

EID: 67651148083     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31818456b9     Document Type: Article

References (25)

1. Claxton AJ, Cramer J, Pierce C. A systemic review of the association between dose regimens and medication compliance. Clin Ther. 2001;23:1296-1310. (Pubitemid 32804122)
2. Olthoff CMG, Schouten JSAG, van de Borne BW, et al. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension. Ophthalmology. 2005; 112:953-961.
3. Sleath B, Robin AL, Covert D, et al. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113:431-436. (Pubitemid 43296984)
4. Tsai JC, McClure CA, Ramos SE, et al. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12: 393-398.
5. Herdon LW, Brunner TA, Rollins JN. The Glaucoma Research Foundation patient survey: patient understanding of glaucoma and its treatment. Am J Ophthalmol. 2006;141: S22-S27.
6. Kharod BV, Johnson PB, Nesti HA, et al. Effect of written instructions on accuracy of self-reporting medication regimen in glaucoma patients. J Glaucoma. 2006;15:244-247.
7. Lim MC, Shiba DR, Clarc IJ, et al. Personality type of the glaucoma patient. J Glaucoma. 2007;16:649-654.
8. Jayawant SS, Bhosle MJ, Anderson RT, et al. Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma. J Glaucoma. 2007;16:513-520.
9. Carrieri PB, Gentile S, Fusco R, et al. Mood disorders in patients with chronic simple glaucoma. Psychiatry Res. 1991; 36:233-235.
10. Jampel HD, Frick KD, Janz NK, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144:238-244.
11. Pappa C, Hyphantis T, Pappa S, et al. Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment. J Psychosom Res. 2006;61:609-617. (Pubitemid 44647259)
12. Robin A, Novack GD, Covert DV, et al. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144:533-540. (Pubitemid 47429615)
13. Flowers B, Wand M, Piltz-Seymour J, et al. Patients' and physicians' perceptions of the Travoprost Dosing Aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension. Clin Ther. 2006;28:1803-1811. (Pubitemid 46038521)
14. Cronin TH, Kahook MY, Lathrop KL, et al. Accuracy and performance of a commercially available dosing aid. Br J Ophthalmol. 2007;91:497-499. (Pubitemid 46623684)
15. Kass MA, Meltzer DW, Gordon M, et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101: 515-523.
16. Kass MA, Gordon M, Morley RE, et al. Compliance with topical timolol treatment. Am J Ophthalmol. 1987;103: 188-193.
17. Schwartz GF. Compliance and persistence in glaucoma followup treatment. Curr Opin Ophthalmol. 2005;16:114-121.
18. Strauman TJ. Self-discrepancies in clinical depression and social phobia: cognitive structures that underline emotional disorders? J Abnorm Psychol. 1989;98:14-22.
19. Sackeim HA, Wegner AZ. Attributional patterns in depression and euthymia. Arch Gen Psychiatry. 1986;43:553-560.
20. Carver CS, Ganellen RJ, Behar-Mitrani V. Depression and cognitive style: comparison between measures. J Pers Soc Psychol. 1985;49:722-728.
21. Sipos K, Sipos M. The development and validation of the Hungarian form of the STAI. In: Spielberger CD, Guerrero D, eds. Cross-Cultural Anxiety. 2nd ed. Washington; London: Hemisphere Publishing Corp; 1978:51-56.
22. Eysenck SBG, Matolcsi A. Development and validation of the Hungarian form of Eysenck Personality Questionnaire (EPQ): a comparison study among Hungarian and English adults. Psychiat Hung. 1984;2:231-240.
23. Perczel-Forintos D, Sallai J, Ró zsa S. Reliability and validity of the Beck Hopeless Scale. Psychiat Hung. 2001;16:632-643.
24. Ró zsa S, Szá dó czky E, Fü redi J. Validation of the shortened version of BDI. Psychiat Hung. 2001;16:384-402.
25. Wilensky J, Fiscella RG, Carlson AM, et al. Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data. Am J Ophthalmol. 2006;141:S28-S33. (Pubitemid 43028477)